BCAL Diagnostics LimitedASX: BDX

BREASTESTplus Research Presented at Lipidomic Conference

· Issued by BCAL Diagnostics Limited via ASX

Filed with ASX ·

ASX Announcement 19 October 2026 BCAL Diagnostics presents BREASTESTplus research at International Lipidomic Conference Highlights • BCAL's research underpinning BREASTESTplus™ 2 has been presented as a scientific poster at the Australian Lipid Meeting and International Lipidomic Society...

View Attachment

6ix hasn’t read this filing yet.

BCAL Diagnostics Limited on 6ix

In the deck

Earlier from BCAL Diagnostics

Later from BCAL Diagnostics

All BCAL Diagnostics news releases